Amisulpride Impurity-B CAS 148516-54-5
New Products
![Structure of N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide CAS 69444-90-2](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7 "Structure of N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide <span class=\"caps\">CAS</span> 69444-90-2")
N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide CAS 69444-90-2Identification […]- Red 8 CAS 33270-70-1Identification […]
- 1-chloro-6,6-dimethyl-2-heptyene-4-alkyne CAS 126764-17-81-chloro-6,6-dimethyl-2-heptyene-4-alkyne,126764-17-8,1-Chloro-6,6-dimethyl-2-hepten-4-yne,C9H13Cl […]
- cefuroxime sodium Impurity F CAS 97170-19-9cefuroxime sodium Impurity F,97170-19-9,Cefuroxime Sodium […]
- Levothyroxine sodium CAS 55-03-8(25416-65-3)Levothyroxine sodium,200-221-4(55-03-8),,C15H10I4NNaO4 […]
- Sclareolide CAS 564-20-5Sclareolide,564-20-5,(3aR)-(+)-Sclareolide […]
- Fmoc-D-Homoarg(Et)2-OH(·HCl) CAS AANA-0123Identification […]
- meso-Butane-1,2,3,4-tetracarboxylic Dianhydride CAS 17309-39-617309-39-6,meso-Butane-1,2,3,4-tetracarboxylic Dianhydride,meso-Butane-1,2,3,4-tetracarboxylic Dianhydride […]
- Fmoc-HoArg(Pbf)-OH CAS 401915-53-5Fmoc-HoArg(Pbf)-OH,401915-53-5,Fmoc-Nw-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-homoarginine,C35H42N4O7S […]
- Topiramate CAS 97240-79-4Topiramate,97240-79-4,2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate […]
![Structure of N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide CAS 69444-90-2](https://www.watson-int.com/wp-content/uploads/2021/05/Structure-of-N-2-34-dimethoxyphenylethyl-34-dimethoxycinnamic-acid-amide-CAS-69444-90-2.png "Structure of N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide <span class=\"caps\">CAS</span> 69444-90-2")
© 2026 WATSON INTERNATIONAL LIMITED. All Rights Reserved. This site and all content are protected by international Copyright laws. Third party logos and marks appearing on this website are trademarks and/or registered trademarks of their respective owners and licensors, and all rights therein and thereto are reserved to such entities.